On June 6, 2022 Imago BioSciences, Inc. ("Imago" or the "Company") (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering and developing new medicines for the treatment of myeloproliferative neoplasms (MPNs) and other bone marrow diseases, reported that a virtual investor event will be hosted by the company’s management team following the company’s presentations at EHA (Free EHA Whitepaper) in Vienna, Austria and virtually (Press release, Imago BioSciences, JUN 6, 2022, View Source [SID1234615628]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Individuals interested in listening to the event at 10:30 a.m. ET on Saturday, June 11 may do so by dialing (844) 348-6880 for domestic callers, or (914) 800-3944 for international callers, and reference conference ID: 3493998; or from the webcast link in the investor relations section of the company’s website at: www.imagobio.com. The webcast will be available in the investor relations section on the Company’s website for 90 days following the completion of the call.
Imago will present two posters at EHA (Free EHA Whitepaper) reporting updated data from its Phase 2 studies of bomedemstat for the treatment of Essential Thrombocythemia and Myelofibrosis, respectively.
The titles of the poster presentations are:
Poster Presentation Title: "A Phase 2 Study of IMG-7289 (Bomedemstat) in Patients with Advanced Myelofibrosis"
Presentation Date & Time: Friday, June 10, 2022, at 10:30 AM ET
Poster Presentation Title: "A Phase 2 Study of the LSD1 Inhibitor IMG-7289 (Bomedemstat) for the Treatment of Essential Thrombocythemia (ET)"
Presentation Date & Time: Friday, June 10, 2022, at 10:30 AM ET
The abstracts are available on the EHA (Free EHA Whitepaper) meeting website at www.journals.lww.com, as an official supplement of HemaSphere, and can also be accessed through "Events and Presentations" on Imago’s investor relations website.